ESOM在其2025年柏林大会上推出了ELCAP,这是在癌症护理中安全使用AI的第一个全球指南。 ESMO launched ELCAP, the first global guidance for safe AI use in cancer care, at its 2025 Berlin Congress.

欧洲医疗肿瘤学学会(ESMO)在柏林举行的2025年大会上推出了ELCAP,这是在癌症护理中使用人工智能语言模式的第一个全面指南。 The European Society for Medical Oncology (ESMO) launched ELCAP, the first comprehensive guidance for using artificial intelligence language models in cancer care, at its 2025 Congress in Berlin. 框架将AI工具分类为以病人为主、以临床为主和背景的系统,每个系统都要求具体的安全、监督和验证措施。 Published in Annals of Oncology, the framework categorizes AI tools into patient-facing, clinician-facing, and background systems, each requiring specific safety, oversight, and validation measures. ELCAP强调数据保护、临床监督和问责,以确保AI支持而不是取代医疗判断。 ELCAP emphasizes data protection, clinical supervision, and accountability to ensure AI supports, rather than replaces, medical judgment. 由45 000名肿瘤专业人员组成的全球网络,EMSO旨在为癌症治疗的伦理自理整合建立可信赖的标准。 With a global network of 45,000 oncology professionals, ESMO aims to establish trusted standards for ethical AI integration in cancer treatment.